LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Clinical trials for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo aims to stall advanced bladder cancer
Disease control TerminatedThis study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy helps people with advanced bladder cancer that has not been treated before. Participants have a type of bladder cancer that has spread or cannot be removed by surgery and shows a protein c…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy aims to keep bladder cancer at bay after chemo
Disease control OngoingThis phase 2 trial tests whether adding avelumab (an immunotherapy) to another anti-cancer drug (sacituzumab govitecan) can help prevent advanced bladder cancer from growing after initial chemotherapy. About 256 participants with locally advanced or metastatic urothelial carcinom…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC